{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T01:17:40Z","timestamp":1792977460276,"version":"4.5.0"},"reference-count":184,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T00:00:00Z","timestamp":1669075200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>The incidence of heart failure with preserved ejection fraction is increasing in patients with obesity, diabetes, hypertension, and in the aging population. However, there is a lack of adequate clinical treatment. Patients with obesity-related heart failure with preserved ejection fraction display unique pathophysiological and phenotypic characteristics, suggesting that obesity could be one of its specific phenotypes. There has been an increasing recognition that overnutrition in obesity causes adipose tissue expansion and local and systemic inflammation, which consequently exacerbates cardiac remodeling and leads to the development of obese heart failure with preserved ejection fraction. Furthermore, overnutrition leads to cellular metabolic reprogramming and activates inflammatory signaling cascades in various cardiac cells, thereby promoting maladaptive cardiac remodeling. Growing evidence indicates that the innate immune response pathway from the NLRP3 inflammasome, to interleukin-1 to interleukin-6, is involved in the generation of obesity-related systemic inflammation and heart failure with preserved ejection fraction. This review established the existence of obese heart failure with preserved ejection fraction based on structural and functional changes, elaborated the inflammation mechanisms of obese heart failure with preserved ejection fraction, proposed that NLRP3 inflammasome activation may play an important role in adiposity-induced inflammation, and summarized the potential therapeutic approaches.<\/jats:p>","DOI":"10.3389\/fimmu.2022.947147","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:14:20Z","timestamp":1669104860000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":35,"title":["Inflamed adipose tissue: A culprit underlying obesity and heart failure with preserved ejection fraction"],"prefix":"10.3389","volume":"13","author":[{"given":"Chenyu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglu","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarui","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Die","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bilian","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,11,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(18)32279-7","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the global burden of disease study 2017","volume":"392","year":"2018","journal-title":"Lancet (London England)"},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: A multiorgan roadmap","volume":"134","author":"Shah","year":"2016","journal-title":"Circulation"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz641","article-title":"How to diagnose heart failure with preserved ejection fraction: the HFA-PEFF diagnostic algorithm: a consensus recommendation from the heart failure association (HFA) of the European society of cardiology (ESC)","volume":"40","author":"Pieske","year":"2019","journal-title":"Eur Heart J"},{"key":"B4","unstructured":"Obesity and overweight facts"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.296.18.2209","article-title":"Systolic and diastolic heart failure in the community","volume":"296","author":"Bursi","year":"2006","journal-title":"JAMA"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the irbesartan in heart failure with preserved ejection fraction (I-PRESERVE) trial","volume":"4","author":"Haass","year":"2011","journal-title":"Circ Heart Failure"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.119.006414","article-title":"Obese-inflammatory phenotypes in heart failure with preserved ejection fraction","volume":"13","author":"Sabbah","year":"2020","journal-title":"Circ Heart Fail Aug"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.120.045810","article-title":"Proteomic evaluation of the comorbidity-inflammation paradigm in heart failure with preserved ejection fraction: Results from the PROMIS-HFpEF study","volume":"142","author":"Sanders-van Wijk","year":"2020","journal-title":"Circulation"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.32.5.740","article-title":"The cardiac pathology of chronic exogenous obesity","volume":"32","author":"Amad","year":"1965","journal-title":"Circulation"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(95)90445-x","article-title":"Sudden death as a result of heart disease in morbid obesity","volume":"130","author":"Duflou","year":"1995","journal-title":"American Heart J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-7","article-title":"Cardiac dysfunction in the diabetic rat: quantitative evaluation using high resolution magnetic resonance imaging","volume":"5","author":"Loganathan","year":"2006","journal-title":"Cardiovasc Diabetology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/hrt.2005.080150","article-title":"Characteristics of left ventricular diastolic dysfunction in the community: an echocardiographic survey","volume":"92","author":"Abhayaratna","year":"2006","journal-title":"Heart (British Cardiac Society)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00030.2020","article-title":"Obesity cardiomyopathy: evidence, mechanisms, and therapeutic implications","volume":"101","author":"Ren","year":"2021","journal-title":"Physiol Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/nu12020412","article-title":"Different patterns of left ventricular hypertrophy in metabolically healthy and insulin-resistant obese subjects","volume":"12","author":"Sciacqua","year":"2020","journal-title":"Nutrients"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.hlc.2016.06.1212","article-title":"Metabolic abnormalities, but not metabolically healthy obesity, are associated with left ventricular hypertrophy","volume":"26","author":"Zhang","year":"2017","journal-title":"Heart Lung Circulation"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.6.2001092","article-title":"Echocardiographic features of the right heart in sleep-disordered breathing: the framingham heart study","volume":"164","author":"Guidry","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1161\/circulationaha.113.001873","article-title":"Right ventricular diastolic impairment in patients with pulmonary arterial hypertension","volume":"128","author":"Rain","year":"2013","journal-title":"Circulation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1080\/08037050902850226","article-title":"Left and right ventricular structural changes in obese hypertensives","volume":"18","author":"Masaidi","year":"2009","journal-title":"Blood Pressure"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.015","article-title":"Association of subclinical right ventricular dysfunction with obesity","volume":"47","author":"Wong","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9149(92)90739-l","article-title":"Cardiomyopathy of obesity: a clinicopathologic evaluation of 43 obese patients with heart failure","volume":"70","author":"Kasper","year":"1992","journal-title":"Am J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1161\/01.cir.92.9.2385","article-title":"Pressure- and volume-induced left ventricular hypertrophies are associated with distinct myocyte phenotypes and differential induction of peptide growth factor mRNAs","volume":"92","author":"Calderone","year":"1995","journal-title":"Circulation"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00898.2014","article-title":"Mineralocorticoid receptor blockade prevents Western diet-induced diastolic dysfunction in female mice","volume":"308","author":"Bostick","year":"2015","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00238.2018","article-title":"Characterization of a mouse model of obesity-related fibrotic cardiomyopathy that recapitulates features of human heart failure with preserved ejection fraction","volume":"315","author":"Alex","year":"2018","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.114.009625","article-title":"Coronary microvascular rarefaction and myocardial fibrosis in heart failure with preserved ejection fraction","volume":"131","author":"Mohammed","year":"2015","journal-title":"Circulation"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.114.001293","article-title":"Impaired myocardial oxygen availability contributes to abnormal exercise hemodynamics in heart failure with preserved ejection fraction","volume":"3","author":"van Empel","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/obr.12828","article-title":"Hypoxia-inducible factor 1-alpha (HIF-1\u03b1) as a factor mediating the relationship between obesity and heart failure with preserved ejection fraction","volume":"20","author":"Warbrick","year":"2019","journal-title":"Obes Reviews: An Off J Int Assoc Study Obes"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1974-7","article-title":"The effects of obesity and type 2 diabetes mellitus on cardiac structure and function in adolescents and young adults","volume":"54","author":"Shah","year":"2011","journal-title":"Diabetologia"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-014-0548-z","article-title":"Myocardial tissue phase mapping reveals impaired myocardial tissue velocities in obesity","volume":"31","author":"Rider","year":"2015","journal-title":"Int J Cardiovasc Imaging"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2010.10.042","article-title":"Effect of obesity and overweight on left ventricular diastolic function: a community-based study in an elderly cohort","volume":"57","author":"Russo","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2014.03.014","article-title":"Impact of general and central adiposity on ventricular-arterial aging in women and men","volume":"2","author":"Wohlfahrt","year":"2014","journal-title":"JACC Heart Failure"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.106.659763","article-title":"Cardiac structure and ventricular-vascular function in persons with heart failure and preserved ejection fraction from Olmsted county, Minnesota","volume":"115","author":"Lam","year":"2007","journal-title":"Circulation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1159\/000072588","article-title":"Evaluation of the cardiovascular system in children with simple obesity. part II. echocardiographic assessment","volume":"21","author":"Koehler","year":"1989","journal-title":"Materia Med Polona Polish J Med Pharm"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(94)90018-3","article-title":"Obesity, pregnancy, and left ventricular functioning during the third trimester","volume":"171","author":"Veille","year":"1994","journal-title":"Am J Obstetrics Gynecology"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(92)90280-9","article-title":"The influence of obesity on left ventricular filling and systolic function","volume":"124","author":"Stoddard","year":"1992","journal-title":"Am Heart J"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.eurheartj.a060249","article-title":"Left ventricular diastolic and systolic function in normotensive obese subjects: influence of degree and duration of obesity","volume":"13","author":"Scaglione","year":"1992","journal-title":"Eur Heart J"},{"key":"B37","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1148\/radiology.169.1.3420283","article-title":"Human heart: tagging with MR imaging\u2013a method for noninvasive assessment of myocardial motion","volume":"169","author":"Zerhouni","year":"1988","journal-title":"Radiology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s0894-7317(14)80001-1","article-title":"Color Doppler myocardial imaging: a new technique for the assessment of myocardial function","volume":"7","author":"Sutherland","year":"1994","journal-title":"J Am Soc Echocardiography Off Publ Am Soc Echocardiogr"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2015.11.001","article-title":"Tissue tracking technology for assessing cardiac mechanics: Principles, normal values, and clinical applications","volume":"8","author":"Claus","year":"2015","journal-title":"JACC Cardiovasc Imaging"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1093\/ehjci\/jez041","article-title":"Myocardial strain imaging: review of general principles, validation, and sources of discrepancies","volume":"20","author":"Amzulescu","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000147184.13872.0f","article-title":"Alterations of left ventricular myocardial characteristics associated with obesity","volume":"110","author":"Wong","year":"2004","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1161\/circulationaha.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","author":"Obokata","year":"2017","journal-title":"Circulation"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1378\/chest.11-0172","article-title":"Obesity and right ventricular structure and function: the MESA-right ventricle study","volume":"141","author":"Chahal","year":"2012","journal-title":"Chest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.630","article-title":"Right ventricular dysfunction in heart failure with preserved ejection fraction: a systematic review and meta-analysis","volume":"18","author":"Gorter","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B45","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/ejhf.418","article-title":"The right heart in heart failure with preserved ejection fraction: insights from cardiac magnetic resonance imaging and invasive haemodynamics","volume":"18","author":"Aschauer","year":"2016","journal-title":"Eur J Heart Fail"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw241","article-title":"Abnormal right ventricular-pulmonary artery coupling with exercise in heart failure with preserved ejection fraction","volume":"37","author":"Borlaug","year":"2016","journal-title":"Eur Heart J"},{"key":"B47","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1161\/01.Cir.0000112582.16683.Ea","article-title":"Impact of obesity on plasma natriuretic peptide levels","volume":"109","author":"Wang","year":"2004","journal-title":"Circulation"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2003.10.066","article-title":"Obesity and suppressed b-type natriuretic peptide levels in heart failure","volume":"43","author":"Mehra","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"B49","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jacc.2005.08.050","article-title":"B-type natriuretic peptide levels in obese patients with advanced heart failure","volume":"47","author":"Horwich","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.11.022","article-title":"Is brain natriuretic peptide production decreased in obese subjects","volume":"47","author":"van Kimmenade","year":"2006","journal-title":"J Am College Cardiology"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.032474","article-title":"Leptin-Aldosterone-Neprilysin axis: Identification of its distinctive role in the pathogenesis of the three phenotypes of heart failure in people with obesity","volume":"137","author":"Packer","year":"2018","journal-title":"Circulation"},{"key":"B52","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.trsl.2017.06.001","article-title":"Modulation of natriuretic peptide receptors in human adipose tissue: molecular mechanisms behind the \"natriuretic handicap\" in morbidly obese patients","volume":"186","author":"Gentili","year":"2017","journal-title":"Transl Res Aug"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfr079","article-title":"Can emerging biomarkers of myocardial remodelling identify asymptomatic hypertensive patients at risk for diastolic dysfunction and diastolic heart failure","volume":"13","author":"Collier","year":"2011","journal-title":"Eur J Heart Failure"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","author":"Paulus","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2019.09.009","article-title":"Clinical phenogroups in heart failure with preserved ejection fraction: Detailed phenotypes, prognosis, and response to spironolactone","volume":"8","author":"Cohen","year":"2020","journal-title":"JACC Heart Failure"},{"key":"B56","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s11886-017-0912-4","article-title":"Hypertension in obesity and the impact of weight loss","volume":"19","author":"Cohen","year":"2017","journal-title":"Curr Cardiol Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2020.02.004","article-title":"Obesity-related heart failure with preserved ejection fraction: Pathophysiology, diagnosis, and potential therapies","volume":"16","author":"Harada","year":"2020","journal-title":"Heart failure clinics"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx012","article-title":"Inflammation and metabolic cardiomyopathy","volume":"113","author":"Nishida","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.742178","article-title":"Inflammation in metabolic cardiomyopathy","volume":"8","author":"Wenzl","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.120.317933","article-title":"Targeting mitochondria-inflammation circuit by \u03b2-hydroxybutyrate mitigates HFpEF","volume":"128","author":"Deng","year":"2021","journal-title":"Circ Res"},{"key":"B61","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/nm1775","article-title":"Leptin controls adipose tissue lipogenesis via central, STAT3-independent mechanisms","volume":"14","author":"Buettner","year":"2008","journal-title":"Nat Med"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1998.275.2.E259","article-title":"Leptin induction of UCP1 gene expression is dependent on sympathetic innervation","volume":"275","author":"Scarpace","year":"1998","journal-title":"Am J Physiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3800","article-title":"LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes","volume":"21","author":"Li","year":"2015","journal-title":"Nat Med"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2015.00637","article-title":"The macrophage switch in obesity development","volume":"6","author":"Castoldi","year":"2015","journal-title":"Front Immunol"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/nm.1964","article-title":"CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity","volume":"15","author":"Nishimura","year":"2009","journal-title":"Nat Med"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.680944","article-title":"High fat diet-induced CD8 + T cells in adipose tissue mediate macrophages to sustain low-grade chronic inflammation","volume":"12","author":"Kiran","year":"2021","journal-title":"Front Immunol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.117.029617","article-title":"Cardiovascular and metabolic heterogeneity of obesity: Clinical challenges and implications for management","volume":"137","author":"Neeland","year":"2018","journal-title":"Circulation"},{"key":"B70","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12933-017-0528-4","article-title":"Regulation of visceral and epicardial adipose tissue for preventing cardiovascular injuries associated to obesity and diabetes","volume":"16","author":"Gonz\u00e1lez","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2021.720690","article-title":"Epicardial fat expansion in diabetic and obese patients with heart failure and preserved ejection fraction-a specific HFpEF phenotype","volume":"8","author":"Elsanhoury","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2840-5-1","article-title":"Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease","volume":"5","author":"Baker","year":"2006","journal-title":"Cardiovasc Diabetology"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy331","article-title":"Borlaug BA. exercise unmasks distinct pathophysiologic features in heart failure with preserved ejection fraction and pulmonary vascular disease","volume":"39","author":"Gorter","year":"2018","journal-title":"Eur Heart J"},{"key":"B74","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1161\/circheartfailure.109.931451","article-title":"Cardiac inflammation contributes to changes in the extracellular matrix in patients with heart failure and normal ejection fraction","volume":"4","author":"Westermann","year":"2011","journal-title":"Circ Heart Failure"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.414","article-title":"Circulating biomarkers of distinct pathophysiological pathways in heart failure with preserved vs. reduced left ventricular ejection fraction","volume":"17","author":"Sanders-van Wijk","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00240.x","article-title":"Endothelium-dependent contractions and endothelial dysfunction in human hypertension","volume":"157","author":"Versari","year":"2009","journal-title":"Br J Pharmacol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1161\/01.res.86.5.494","article-title":"NAD(P)H oxidase: role in cardiovascular biology and disease","volume":"86","author":"Griendling","year":"2000","journal-title":"Circ Res"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/jaha.116.004133","article-title":"Heart failure, left ventricular remodeling, and circulating nitric oxide metabolites","volume":"5","author":"Chirinos","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"B79","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1161\/circresaha.117.311401","article-title":"Reactive oxygen species in metabolic and inflammatory signaling","volume":"122","author":"Forrester","year":"2018","journal-title":"Circ Res"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1161\/01.res.0000043825.01705.1b","article-title":"Inflammatory mediators and the failing heart: past, present, and the foreseeable future","volume":"91","author":"Mann","year":"2002","journal-title":"Circ Res"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1172\/jci117956","article-title":"Interleukin-1 beta induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture","volume":"95","author":"Palmer","year":"1995","journal-title":"J Clin Invest"},{"key":"B82","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/cvr\/cvp040","article-title":"IL-10 attenuates TNF-alpha-induced NF kappaB pathway activation and cardiomyocyte apoptosis","volume":"82","author":"Dhingra","year":"2009","journal-title":"Cardiovasc Res"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.108.846105","article-title":"Tumor necrosis factor-alpha and its receptors 1 and 2: Yin and yang in myocardial infarction","volume":"119","author":"Schulz","year":"2009","journal-title":"Circulation"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-0419com","article-title":"TNF-alpha signal transduction in rat neonatal cardiac myocytes: definition of pathways generating from the TNF-alpha receptor","volume":"16","author":"Condorelli","year":"2002","journal-title":"FASEB J Off Publ Fed Am Societies Exp Biol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.109.208199","article-title":"Pressure-mediated hypertrophy and mechanical stretch induces IL-1 release and subsequent IGF-1 generation to maintain compensative hypertrophy by affecting akt and JNK pathways","volume":"105","author":"Honsho","year":"2009","journal-title":"Circ Res"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2022.155811","article-title":"The interleukin-1 receptor type I promotes the development of aging-associated cardiomyopathy in mice","volume":"151","author":"Narayan","year":"2022","journal-title":"Cytokine"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1016\/s1010-7940(01)01031-4","article-title":"Myocardial fluid balance","volume":"20","author":"Mehlhorn","year":"2001","journal-title":"Eur J cardio-thoracic Surg Off J Eur Assoc Cardio-thoracic Surgery"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-009-0420-x","article-title":"Age-related lymphatic dysfunction in melanoma patients","volume":"16","author":"Conway","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00664.2015","article-title":"Blunted flow-mediated responses and diminished nitric oxide synthase expression in lymphatic thoracic ducts of a rat model of metabolic syndrome","volume":"310","author":"Zawieja","year":"2016","journal-title":"Annals of Surgical Oncol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1172\/jci22037","article-title":"Pathogenesis of persistent lymphatic vessel hyperplasia in chronic airway inflammation","volume":"115","author":"Baluk","year":"2005","journal-title":"J Clin Invest"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1172\/jci119354","article-title":"Impaired microvascular dilatation and capillary rarefaction in young adults with a predisposition to high blood pressure","volume":"99","author":"Noon","year":"1997","journal-title":"J Clin Invest"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-020-0798-y","article-title":"Microvascular and lymphatic dysfunction in HFpEF and its associated comorbidities","volume":"115","author":"Cuijpers","year":"2020","journal-title":"Basic Res Cardiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1161\/01.Cir.0000140973.60992.9a","article-title":"Increased collagen type I synthesis in patients with heart failure of hypertensive origin: relation to myocardial fibrosis","volume":"110","author":"Querejeta","year":"2004","journal-title":"Circulation"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0068893","article-title":"Interleukin-16 promotes cardiac fibrosis and myocardial stiffening in heart failure with preserved ejection fraction","volume":"8","author":"Tamaki","year":"2013","journal-title":"PLos One"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1097\/fjc.0000000000000858","article-title":"Insight into the pro-inflammatory and profibrotic role of macrophage in heart failure with preserved ejection fraction","volume":"76","author":"Shen","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.115.020143","article-title":"Selective stimulation of cardiac lymphangiogenesis reduces myocardial edema and fibrosis leading to improved cardiac function following myocardial infarction","volume":"133","author":"Henri","year":"2016","journal-title":"Circulation"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.113.300376","article-title":"Cardiac metabolism in heart failure: implications beyond ATP production","volume":"113","author":"Doenst","year":"2013","journal-title":"Circ Res"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(63)91500-9","article-title":"The glucose fatty-acid cycle. its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus","volume":"1","author":"RANDLE","year":"1963","journal-title":"Lancet (London England)"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy596","article-title":"Heart failure and diabetes: metabolic alterations and therapeutic interventions: a state-of-the-art review from the translational research committee of the heart failure association-European society of cardiology","volume":"39","author":"Maack","year":"2018","journal-title":"Eur Heart J"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx002","article-title":"The subcellular localisation of neuronal nitric oxide synthase determines the downstream effects of NO on myocardial function","volume":"113","author":"Carnicer","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.2337\/db13-1577","article-title":"Inhibition of JNK phosphorylation by a novel curcumin analog prevents high glucose-induced inflammation and apoptosis in cardiomyocytes and the development of diabetic cardiomyopathy","volume":"63","author":"Pan","year":"2014","journal-title":"Diabetes"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-1756-z","article-title":"High levels of glucose induce \"metabolic memory\" in cardiomyocyte via epigenetic histone H3 lysine 9 methylation","volume":"39","author":"Yu","year":"2012","journal-title":"Mol Biol Rep"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.119.316288","article-title":"Hyperglycemia acutely increases cytosolic reactive oxygen species via O -linked GlcNAcylation and CaMKII activation in mouse ventricular myocytes","volume":"126","author":"Lu","year":"2020","journal-title":"Circ Res"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.13743","article-title":"Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation","volume":"22","author":"Zhang","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B105","doi-asserted-by":"publisher","DOI":"10.3390\/cells10010051","article-title":"Role of cardiac macrophages on cardiac inflammation, fibrosis and tissue repair","volume":"10","author":"Lafuse","year":"2020","journal-title":"Cells"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.746151","article-title":"Meta-inflammation and metabolic reprogramming of macrophages in diabetes and obesity: The importance of metabolites","volume":"12","author":"Russo","year":"2021","journal-title":"Front Immunol"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"B108","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1161\/circresaha.119.312321","article-title":"Obesity, hypertension, and cardiac dysfunction: Novel roles of immunometabolism in macrophage activation and inflammation","volume":"126","author":"Mouton","year":"2020","journal-title":"Circ Res"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/nature11986","article-title":"Succinate is an inflammatory signal that induces IL-1\u03b2 through HIF-1\u03b1","volume":"496","author":"Tannahill","year":"2013","journal-title":"Nature"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(90)90984-a","article-title":"Metabolism of exogenous substrates by coronary endothelial cells in culture","volume":"22","author":"Kr\u00fctzfeldt","year":"1990","journal-title":"J Mol Cell Cardiol"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1007\/bf00223424","article-title":"Fatty acids are not an important fuel for coronary microvascular endothelial cells","volume":"88","author":"Spahr","year":"1989","journal-title":"Mol Cell Biochem"},{"key":"B112","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1161\/circresaha.120.318805","article-title":"Immunometabolic endothelial phenotypes: Integrating inflammation and glucose metabolism","volume":"129","author":"Xiao","year":"2021","journal-title":"Circ Res"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2013.06.022","article-title":"Innate sensors of pathogen and stress: linking inflammation to obesity","volume":"132","author":"Jin","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1161\/circresaha.118.311362","article-title":"NLRP3 inflammasome and the IL-1 pathway in atherosclerosis","volume":"122","author":"Grebe","year":"2018","journal-title":"Circ Res"},{"key":"B115","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jacbts.2021.08.006","article-title":"Targeting the inflammasome in cardiovascular disease","volume":"7","author":"Olsen","year":"2022","journal-title":"JACC Basic to Trans science"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2279","article-title":"The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance","volume":"17","author":"Vandanmagsar","year":"2011","journal-title":"Nat Med"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.3390\/cells10040951","article-title":"Targeting inflammatory pathways in cardiovascular disease: The inflammasome, interleukin-1, interleukin-6 and beyond","volume":"10","author":"Libby","year":"2021","journal-title":"Cells"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.02.054","article-title":"The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation","volume":"153","author":"Subramanian","year":"2013","journal-title":"Cell"},{"key":"B119","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/imr.12286","article-title":"Initiation and perpetuation of NLRP3 inflammasome activation and assembly","volume":"265","author":"Elliott","year":"2015","journal-title":"Immunol Rev"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1038\/nature09663","article-title":"A role for mitochondria in NLRP3 inflammasome activation","volume":"469","author":"Zhou","year":"2011","journal-title":"Nature"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1301170","article-title":"The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity","volume":"191","author":"Park","year":"2013","journal-title":"J Immunol (Baltimore Md 1950)"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2013.08.001","article-title":"Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation","volume":"39","author":"Iyer","year":"2013","journal-title":"Immunity"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1100255108","article-title":"Inflammasome is a central player in the induction of obesity and insulin resistance","volume":"108","author":"Stienstra","year":"2011","journal-title":"Proc Natl Acad Sci United States America"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1007\/s11356-021-14904-4","article-title":"Targeting NLRP3 inflammasome as a chief instigator of obesity, contributing to local adipose tissue inflammation and insulin resistance","volume":"28","author":"Sehgal","year":"2021","journal-title":"Environ Sci pollut Res Int"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2022","article-title":"Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling","volume":"12","author":"Wen","year":"2011","journal-title":"Nat Immunol"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.2337\/db14-1098","article-title":"Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1\u03b2 secretion and insulin resistance despite obesity","volume":"64","author":"Finucane","year":"2015","journal-title":"Diabetes"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P035808","article-title":"Plasma lipid profiling in a large population-based cohort","volume":"54","author":"Weir","year":"2013","journal-title":"J Lipid Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2014.09.015","article-title":"CerS2 haploinsufficiency inhibits \u03b2-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance","volume":"20","author":"Raichur","year":"2014","journal-title":"Cell Metab"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3850-y","article-title":"Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans","volume":"59","author":"Bergman","year":"2016","journal-title":"Diabetologia"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1113\/ep088390","article-title":"Knockout of MD1 contributes to sympathetic hyperactivity and exacerbates ventricular arrhythmias following heart failure with preserved ejection fraction via NLRP3 inflammasome activation","volume":"105","author":"Yang","year":"2020","journal-title":"Exp Physiol"},{"key":"B131","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.cmet.2017.06.018","article-title":"Inflammasomes on the crossroads of innate immune recognition and metabolic control","volume":"26","author":"Pr\u00f3chnicki","year":"2017","journal-title":"Cell Metab"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.036259","article-title":"Mitochondrial dysfunction in heart failure with preserved ejection fraction","volume":"139","author":"Kumar","year":"2019","journal-title":"Circulation"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2013.08.047","article-title":"Effects of interleukin-1 blockade with anakinra on aerobic exercise capacity in patients with heart failure and preserved ejection fraction (from the d-HART pilot study)","volume":"113","author":"Van Tassell","year":"2014","journal-title":"Am J Cardiol"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.118.005036","article-title":"IL-1 blockade in patients with heart failure with preserved ejection fraction","volume":"11","author":"Van Tassell","year":"2018","journal-title":"Circ Heart Failure"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"New Engl J Med"},{"key":"B136","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardiores.2005.08.017","article-title":"IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes","volume":"69","author":"Smart","year":"2006","journal-title":"Cardiovasc Res"},{"key":"B137","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(19)86741-8","article-title":"Colchicine inhibition of microtubule assembly via copolymer formation","volume":"254","author":"Sternlicht","year":"1979","journal-title":"J Biol Chem"},{"key":"B138","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.mehy.2016.04.039","article-title":"Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation","volume":"92","author":"Demidowich","year":"2016","journal-title":"Med Hypotheses"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2017.12.027","article-title":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","volume":"269","author":"Mart\u00ednez","year":"2018","journal-title":"Atherosclerosis"},{"key":"B140","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/1871525717666181211110332","article-title":"The beneficial therapy with colchicine for atherosclerosis via anti-inflammation and decrease in hypertriglyceridemia","volume":"16","author":"Spartalis","year":"2018","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"B141","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.mehy.2016.08.006","article-title":"Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation","volume":"95","author":"Nikolaidis","year":"2016","journal-title":"Med Hypotheses"},{"key":"B142","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40256-020-00408-y","article-title":"Inflammation may be the future of cardiovascular risk reduction: Does colchicine have a current indication","volume":"21","author":"Whayne","year":"2021","journal-title":"Am J Cardiovasc Drugs drugs devices other interventions"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/oby.23341","article-title":"Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome","volume":"30","author":"Levine","year":"2022","journal-title":"Obes (Silver Spring Md)"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-021-01828-9","article-title":"Colchicine in ischemic heart disease: the good, the bad and the ugly","volume":"110","author":"D'Amario","year":"2021","journal-title":"Clin Res Cardiol Off J German Cardiac Society"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"New Engl J Med"},{"key":"B146","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the colchicine cardiovascular outcomes trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"European Heart J"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab221","article-title":"Colchicine and the heart","volume":"42","author":"Imazio","year":"2021","journal-title":"Eur Heart J"},{"key":"B149","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2013.11.006","article-title":"Anti-inflammatory treatment with colchicine in stable chronic heart failure: a prospective, randomized study","volume":"2","author":"Deftereos","year":"2014","journal-title":"JACC Heart Failure"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3804","article-title":"The ketone metabolite \u03b2-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease","volume":"21","author":"Youm","year":"2015","journal-title":"Nat Med"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1161\/hypertensionaha.113.02093","article-title":"Calorie restriction attenuates cardiac remodeling and diastolic dysfunction in a rat model of metabolic syndrome","volume":"62","author":"Takatsu","year":"2013","journal-title":"Hypertension (Dallas Tex 1979)"},{"key":"B152","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1016\/j.jacc.2005.08.069","article-title":"Long-term caloric restriction ameliorates the decline in diastolic function in humans","volume":"47","author":"Meyer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B153","doi-asserted-by":"publisher","DOI":"10.1016\/j.hfc.2021.02.002","article-title":"Hypertension and heart failure with preserved ejection fraction","volume":"17","author":"Lee","year":"2021","journal-title":"Heart Fail Clin"},{"key":"B154","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13577","article-title":"Sodium-glucose cotransporter 2 inhibitors regulate ketone body metabolism via inter-organ crosstalk","volume":"21","author":"Kim","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01536-x","article-title":"The SGLT2 inhibitor dapagliflozin in heart failure with preserved ejection fraction: a multicenter randomized trial","volume":"27","author":"Nassif","year":"2021","journal-title":"Nat Med"},{"key":"B156","unstructured":"Farxiga met primary endpoint in DELIVER phase III trial, reducing risk of cardiovascular death or worsening heart failure in patients with preserved ejection fraction2022"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"New Engl J Med"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.752370","article-title":"Potential mechanisms of SGLT2 inhibitors for the treatment of heart failure with preserved ejection fraction","volume":"12","author":"Pabel","year":"2021","journal-title":"Frontiers in Physiology"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.118.034646","article-title":"A simple, evidence-based approach to help guide diagnosis of heart failure with preserved ejection fraction","volume":"138","author":"Reddy","year":"2018","journal-title":"Circulation"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab389","article-title":"Heart failure with preserved ejection fraction in humans and mice: embracing clinical complexity in mouse models","volume":"42","author":"Withaar","year":"2021","journal-title":"Eur Heart J"},{"key":"B161","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejheart.2006.03.001","article-title":"Type II diabetic mice exhibit contractile dysfunction but maintain cardiac output by favourable loading conditions","volume":"8","author":"Van den Bergh","year":"2006","journal-title":"Eur J Heart Failure"},{"key":"B162","doi-asserted-by":"publisher","DOI":"10.1126\/science.7624776","article-title":"Effects of the obese gene product on body weight regulation in ob\/ob mice","volume":"269","author":"Pelleymounter","year":"1995","journal-title":"Sci (New York NY)"},{"key":"B163","doi-asserted-by":"publisher","DOI":"10.1161\/circheartfailure.113.000539","article-title":"Myocardial titin hypophosphorylation importantly contributes to heart failure with preserved ejection fraction in a rat metabolic risk model","volume":"6","author":"Hamdani","year":"2013","journal-title":"Circ Heart Failure"},{"key":"B164","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1161\/circulationaha.111.067801","article-title":"The polyphenols resveratrol and S17834 prevent the structural and functional sequelae of diet-induced metabolic heart disease in mice","volume":"125","author":"Qin","year":"2012","journal-title":"Circulation"},{"key":"B165","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0220707","article-title":"Cardiac inflammation and diastolic dysfunction in hypercholesterolemic rabbits","volume":"14","author":"Nachar","year":"2019","journal-title":"PLos One"},{"key":"B166","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00024.2018","article-title":"Targeted HFpEF therapy based on matchmaking of human and animal models","volume":"315","author":"Barandiar\u00e1n Aizpurua","year":"2018","journal-title":"Am J Physiol Heart Circulatory Physiol"},{"key":"B167","doi-asserted-by":"publisher","DOI":"10.1177\/1535370213520109","article-title":"Impairment of aldehyde dehydrogenase-2 by 4-hydroxy-2-nonenal adduct formation and cardiomyocyte hypertrophy in mice fed a high-fat diet and injected with low-dose streptozotocin","volume":"239","author":"Mali","year":"2014","journal-title":"Exp Biol Med (Maywood NJ)"},{"key":"B168","doi-asserted-by":"publisher","DOI":"10.1007\/s10554-017-1287-8","article-title":"Early detection of left ventricular diastolic dysfunction using conventional and speckle tracking echocardiography in a large animal model of metabolic dysfunction","volume":"34","author":"van den Dorpel","year":"2018","journal-title":"Int J Cardiovasc Imaging"},{"key":"B169","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1100-z","article-title":"Nitrosative stress drives heart failure with preserved ejection fraction","volume":"568","author":"Schiattarella","year":"2019","journal-title":"Nature"},{"key":"B170","doi-asserted-by":"publisher","DOI":"10.7150\/thno.26055","article-title":"Plasma levels of heart failure biomarkers are primarily a reflection of extracardiac production","volume":"8","author":"Du","year":"2018","journal-title":"Theranostics"},{"key":"B171","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvaa256","article-title":"The effects of liraglutide and dapagliflozin on cardiac function and structure in a multi-hit mouse model of heart failure with preserved ejection fraction","volume":"117","author":"Withaar","year":"2021","journal-title":"Cardiovasc Res"},{"key":"B172","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2020.11.012","article-title":"Novel g\u00f6ttingen miniswine model of heart failure with preserved ejection fraction integrating multiple comorbidities","volume":"6","author":"Sharp","year":"2021","journal-title":"JACC Basic to Trans science"},{"key":"B173","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \"Fishing expedition\"","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC Basic to Trans Sci"},{"key":"B174","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.13504","article-title":"Optimizing the discovery and assessment of therapeutic targets in heart failure with preserved ejection fraction","volume":"8","author":"Fusco-Allison","year":"2021","journal-title":"ESC Heart Failure"},{"key":"B175","doi-asserted-by":"publisher","DOI":"10.1007\/s12471-016-0815-9","article-title":"Animal models of heart failure with preserved ejection fraction","volume":"24","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"Netherlands Heart J monthly J Netherlands Soc Cardiol Netherlands Heart Foundation"},{"key":"B176","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.12915","article-title":"ZSF1 rat as animal model for HFpEF: Development of reduced diastolic function and skeletal muscle dysfunction","volume":"7","author":"Schauer","year":"2020","journal-title":"ESC Heart Failure"},{"key":"B177","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1007\/s00395-018-0711-0","article-title":"Of mice and men: models and mechanisms of diabetic cardiomyopathy","volume":"114","author":"Riehle","year":"2018","journal-title":"Basic Res Cardiol"},{"key":"B178","doi-asserted-by":"publisher","DOI":"10.1172\/jci60329","article-title":"Metabolic stress-induced activation of FoxO1 triggers diabetic cardiomyopathy in mice","volume":"122","author":"Battiprolu","year":"2012","journal-title":"J Clin Invest"},{"key":"B179","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1046\/j.1444-2892.2003.00160.x","article-title":"The streptozotocin-diabetic rat as a model of the chronic complications of human diabetes","volume":"12","author":"Wei","year":"2003","journal-title":"Heart Lung Circ"},{"key":"B180","doi-asserted-by":"publisher","DOI":"10.1016\/s0735-1097(99)00436-2","article-title":"Abnormal cardiac function in the streptozotocin-induced non-insulin-dependent diabetic rat: noninvasive assessment with doppler echocardiography and contribution of the nitric oxide pathway","volume":"34","author":"Joffe","year":"1999","journal-title":"J Am Coll Cardiol"},{"key":"B181","doi-asserted-by":"publisher","DOI":"10.1161\/circulationaha.119.042267","article-title":"Female sex is protective in a preclinical model of heart failure with preserved ejection fraction","volume":"140","author":"Tong","year":"2019","journal-title":"Circulation"},{"key":"B182","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J Am Heart Assoc Feb"},{"key":"B183","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2011.06.012","article-title":"Methods in cardiomyocyte isolation, culture, and gene transfer","volume":"51","author":"Louch","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"010901","DOI":"10.1063\/1.5070106","article-title":"Bioengineering adult human heart tissue: How close are we","volume":"3","author":"Mills","year":"2019","journal-title":"APL bioeng"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.947147\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T08:14:26Z","timestamp":1669104866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.947147\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,22]]},"references-count":184,"alternative-id":["10.3389\/fimmu.2022.947147"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.947147","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,22]]},"article-number":"947147"}}